FOXA2 and colorectal carcinoma: Together, the data above revealed that FOXA2 suppression could improve the sensitivity of chemoresistant CRC cells to OXA treatments for CRC suppression by reducing the cell proliferative, migratory, and invasive capacities and inducing ferroptosis.